|
TOP NEWS
Cassava Investors Ink $31M Drug Suit Deal Alongside Appeal
By Bonnie Eslinger
Cassava Sciences investors have asked a Texas federal judge to preliminarily approve a $31 million settlement that ends their claims the pharmaceutical company inflated its stock prices with misleading information about its Alzheimer's drug research, a deal that could be upended if the court's class certification order is reversed on appeal.
Settlement attached |
Read full article »
| Save to favorites »
POLICY & REGULATION
CRYPTO & FINTECH
WHITE COLLAR
DELAWARE
INVESTOR ACTIONS
EMPLOYMENT
BANKRUPTCY
Sorrento RICO Case Naming Jackson Walker Gets Axed
By Alex Wittenberg
A Texas bankruptcy judge blocked a lawsuit in California federal court alleging Jackson Walker LLP and executives at Sorrento Therapeutics and M3 Partners conspired to forum shop in Texas so the drug developer could seek Chapter 11 protection in an "ethically compromised" bankruptcy court, ruling the suit's claims are barred by Sorrento's bankruptcy plan.
Opinion attached |
Read full article »
| Save to favorites »
PEOPLE
EXPERT ANALYSIS
LEGAL INDUSTRY
|